Modulation of antitumor T-cell response alters tumor growth in bone, indeed Lyn(−/−) mice, which have more numerous OCs and a hyperactive myeloid population with an increased T-cell responses, had reduced tumor growth in bone despite enhanced osteolysis. This evidence concerns the gene LYN and neoplasm.